creatine l-carnitine 5000 Each scoop has 5 grams of creatine monohydrate Creatine + Beta Alanine +

* Correspondence: Ya-Jane Lee, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

the function of GCH1 is potentially important for maintaining retinal health and preventing certain ophthalmic diseases, such as age-related macular degeneration and certain types of retinal degenerative diseases

It contains Methylcobalamin and Levocarnitine, which help to address B12 deficiency symptoms such as anaemia, nerve damage, and fatigue

Springer (2011)

Summary Definition History and exam Key diagnostic factors family history of NF1 pain, any location neurological deficits: gross motor delay, general incoordination, school performance problems compromised vision compromised social interactions skin: caf au lait spots, axillary freckling, cutaneous juvenile xanthogranulomas, neurofibromas head and neck: unilateral diffuse plexiform neurofibroma divisions of the trigeminal nerve ophthalmological: visual compromise, optic disc pallor, iris Lisch nodules, choroidal abnormalities central nervous system: signs of hydrocephalus, brain tumours, and/or cerebellar abnormalities peripheral nervous system: palpable mass about neck, brachial plexuses, groin, Hunter's canal, or the popliteal fossae skeletal: tibial dysplasia or pseudarthrosis, sphenoid wing dysplasia, pectus excavatum or carinatum, genu valgum or varum, ankle valgus, pes planus gastrointestinal: severe constipation, obstipation, abdominal pain, gastrointestinal bleeding vascular: neurological problems, abdominal pain (and/or haemorrhage) autism spectrum disorder vascular: hypertension Risk factors parent with type 1 neurofibromatosis (NF1) Diagnostic investigations 1st investigations to order clinical diagnosis Investigations to consider genetic testing to confirm type 1 neurofibromatosis mutation MRI and/or CT scans PET scan biopsy Treatment algorithm phaeochromocytoma malignant peripheral nerve sheath tumour or atypical neurofibromatous neoplasm of uncertain biological potential neurofibromas: non-cutaneous cutaneous headache nervous system eye oral skeletal vascular gastrointestinal haematopoietic psychological pregnancy-related Contributors Authors D

Individually, these steps may seem modest